Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events?

Am J Transplant. 2004 Apr;4(4):475-81. doi: 10.1111/j.1600-6143.2004.00407.x.

Abstract

The aim of this study was to analyze the incidence of ureteral stenosis in a life-supporting human decay-accelerating factor (hDAF) transgenic pig-to-cynomolgus monkey kidney transplantation model and determine the role of possible immunological events in its pathogenesis. Thirty consecutive bi-nephrectomized cynomolgus monkeys received a kidney from hDAF transgenic pigs with or without a ureteral stent. Four monkeys were euthanized prematurely after transplantation. In the remaining 26 cases, the mean survival was 24 +/- 19 days. Except in one case, there was a close relationship between ureter and kidney in terms of type and severity of rejection. There were six ureteral stenoses; five were repaired by stent positioning and resurgery extended survival for an additional 16 +/- 10 days. The stenotic ureters showed diffuse acute humoral xenograft rejection (AHXR), while all cases with no or only focal signs of ureteral rejection never revealed ureteral obstruction. Use of a ureteral stent extends the survival of a xenografted primate, thereby helping to clarify the immunological events surrounding the onset of AHXR in kidneys in long-term xenograft recipients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • CD55 Antigens / metabolism*
  • Constriction, Pathologic / etiology*
  • Constriction, Pathologic / immunology
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / methods*
  • Macaca fascicularis
  • Primates
  • Renal Insufficiency / prevention & control
  • Stents
  • Swine
  • Time Factors
  • Transplantation
  • Transplantation, Heterologous / adverse effects*
  • Transplantation, Heterologous / methods*
  • Ultrasonics
  • Ureter / pathology*

Substances

  • CD55 Antigens
  • Immunosuppressive Agents